FDA approves Axsome Therapeutics' breakthrough rapid-acting antidepressant - Clinical Trials Arena

Submitted by Anonymous (not verified) on Tue, 08/23/2022 - 10:46

FDA approves Axsome Therapeutics' breakthrough rapid-acting antidepressant  Clinical Trials Arena